Package 64980-220-03

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 64980-220-03
Digits Only 6498022003
Product NDC 64980-220
Product ID 64980-220_34812796-3684-4619-a70c-fc93e22d123a
Description

30 TABLET in 1 BOTTLE (64980-220-03)

Marketing

Marketing Status
Marketed Since 2017-08-15
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "34812796-3684-4619-a70c-fc93e22d123a", "openfda": {"upc": ["0364980220033"], "unii": ["KVI301NA53"], "rxcui": ["903847"], "spl_set_id": ["f7a75639-a23a-4847-a962-c091c61947f0"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (64980-220-03)", "package_ndc": "64980-220-03", "marketing_start_date": "20170815"}], "brand_name": "Pyridostigmine Bromide", "product_id": "64980-220_34812796-3684-4619-a70c-fc93e22d123a", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "64980-220", "generic_name": "Pyridostigmine Bromide", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "180 mg/1"}], "application_number": "ANDA205464", "marketing_category": "ANDA", "marketing_start_date": "20170815", "listing_expiration_date": "20261231"}